Correlations Between Mini-Mental State Examination Score, Cerebrospinal Fluid Biomarkers, and Pathology Observed in Brain Biopsies of Patients With Normal-Pressure Hydrocephalus

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease

(2017) Kaj Blennow et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of coexistence of Alzheimer’s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers

(2014) Tae Sung Lim et al.   BMC Neurology

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus

(2014) Okko T. Pyykkö et al.   PLoS One

Increased γ-Secretase Activity in Idiopathic Normal Pressure Hydrocephalus Patients with β-Amyloid Pathology

(2014) Tiina Laiterä et al.   PLoS One

Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus

(2013) Ahmed K. Toma et al.   ACTA NEUROCHIRURGICA

Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers

(2013) A. Jeppsson et al.   NEUROLOGY

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

(2012) Juha O. Rinne et al.   ACTA NEUROPATHOLOGICA

Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus

(2012) M. Miyajima et al.   EUROPEAN JOURNAL OF NEUROLOGY

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

(2012) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cortical Brain Biopsy in Long-Term Prognostication of 468 Patients with Possible Normal Pressure Hydrocephalus

(2012) Ville Leinonen et al.   Neurodegenerative Diseases

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Alzheimer Disease Pathology in Subjects Without Dementia in 2 Studies of Aging: The Nun Study and the Adult Changes in Thought Study

(2011) Karen S. SantaCruz et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

(2011) Heiko Braak et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus

(2011) Andrew Tarnaris et al.   JOURNAL OF NEUROSURGERY

Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature

(2011) V. Leinonen et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

(2010) Ville Leinonen et al.   ANNALS OF NEUROLOGY

Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau

(2010) Balmiki Ray et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

(2009) Irina Alafuzoff et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

The longitudinal profile of CSF markers during external lumbar drainage

(2009) A Tarnaris et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P

(2009) Karen Koopman et al.   NEUROCHEMISTRY INTERNATIONAL

A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment

(2008) Alex J. Mitchell   JOURNAL OF PSYCHIATRIC RESEARCH